Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trilipix in mixed dyslipidemia and severe hypertriglyceridemia (China, Phase 3)
CTR20160753Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibric acid in hypertriglyceridemia, combined dyslipidaemia, hypercholesterolemia, sponsored by Abbott Laboratories. Started Oct 2016; status: completed.
02
Drugs
fenofibric acid
03
Conditions
hypertriglyceridemiacombined dyslipidaemiahypercholesterolemia
Beyond the preview
Go deeper on CTR20160753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160753.